(Q40589361)

21 September 2017

title

Interleukin-2 liposomes for primary immune deficiency using the aerosol route (English)

1 reference

21 September 2017

R M Ten

1

1 reference

21 September 2017

P M Anderson

2

1 reference

21 September 2017

N N Zein

3

1 reference

21 September 2017

Z Temesgen

4

1 reference

21 September 2017

Mary Lou Clawson

5

1 reference

21 September 2017

W Weiss

6

1 reference

21 September 2017

publication date

1 February 2002

1 reference

International Immunopharmacology

21 September 2017

published in

1 reference

21 September 2017

volume

2

1 reference

21 September 2017

issue

2-3

1 reference

21 September 2017

page(s)

333-344

1 reference

Clinical and immunologic analyses of 103 patients with common variable immunodeficiency

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Selective antipolysaccharide antibody deficiency associated with peripheral blood CD5+ B-cell predominance

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

The IL-2 mediated amplification of cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Delivery of interleukin 2 for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Interleukin-2 toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Interleukin-2 in cancer therapy: uses and optimum management of adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Immunologic Effects of Low-Dose Polyethylene Glycol-Conjugated Recombinant Human Interleukin-2 in Common Variable Immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Nebulized interleukin 2 liposomes: aerosol characteristics and biodistribution

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

A comparison of commercial jet nebulizers

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900143-6

7 January 2021

10.1016/S1567-5769(01)00143-6

Identifiers

DOI

1 reference

21 September 2017

1 reference